Positive

William Pao: Breakthrough – The Quest for Life-Changing Medicines

William Pao/citybiz.co

Jan 15, 2025, 15:57

William Pao: Breakthrough – The Quest for Life-Changing Medicines

William Pao, Chief Executive Officer of Revelio Therapeutics, shared a post on LinkedIn:

“Today is book Launch Day in the U.S.! Thrilled to present to you Breakthrough: The Quest for Life-Changing Medicines, available for purchase here.

Breakthrough is a tribute to the hidden heroes of medicine – the visionaries who saw possibilities where others saw dead ends. Their stories of scientific tenacity remind us that every life-saving treatment began with someone brave enough to ask ‘what if?’ and determined enough to seek the answer.

Breakthrough celebrates the researchers, clinicians and others who, through relentless perseverance and scientific courage, chased audacious dreams and transformed mere molecules into miracles that have saved or improved countless lives.

They came up with bold hypotheses, followed their scientific instincts and overcame obstacles, often with the gift of serendipity, to create healing realities.

Here are just a few of the nearly 100 heroes of medicine that are mentioned in my book: Lutz Mueller, Hasane Ratni, Darren Cross, Teresa Klinowska, Thomas Lynch, Tomoyuki Igawa, Gallia Levy, Carlos Garcia-Echeverria, Ph.D., Christine Fritsch, Victor Velculescu, Jennifer Hammond, Dafydd Owen, Stuart Orkin, Daniel Bauer, John Link, and Moupali Das. Thank you all for your impact on society!

I am looking forward to sharing the above stories and key insights into breakthrough innovation in the upcoming months at various events around the country. Comment below if there is an event or company or city that I should plan to visit.”

Erika Hamilton, Director of Breast Cancer Program at Sarah Cannon Research Institute, shared this post, adding:

“Congrats William Pao, MD, PhD, can’t wait to read!”

More posts featuring William Pao and Erika Hamilton.

William Pao is an Adjunct Professor of Pharmacology and Medicine at Joan & Sanford I. Weill Medical College of Cornell University.

He is the Chief Executive Officer of Revelio Therapeutics and serves as an Independent Member of the Board of Directors at Obsidian Therapeutics and Alentis Therapeutics. He is also a member of the Board of Directors for the American Association for Cancer Research.

Erika Hamilton is a medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute (USA).

Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee.

She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.